Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them

Behavioural Brain Research

Volumn 200, Issue 1, 2009, Pages 165-172

  Conti, Lisa H ^a   Sutherland, Jane E ^a   Muhlhauser, Carey M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Acoustic startle; Brown Norway; CRF; Heritability; Prepulse inhibition; Startle modulation; Wistar Kyoto

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; BROWN NORWAY RAT; CONTROLLED STUDY; CROSS BREEDING; HERITABILITY; INBRED STRAIN; INHERITANCE; MALE; NONHUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROGENY; RAT; SPRAGUE DAWLEY RAT; STARTLE REFLEX; WISTAR KYOTO RAT;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; MALE; NEURAL INHIBITION; PSYCHOACOUSTICS; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; REACTION TIME; SPECIES SPECIFICITY; STARTLE REACTION; TIME FACTORS;

EID: 62649146832     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.01.008     Document Type: Article

References (65)

1. Hammond G.R., McAdam D.W., and Ison J.R. Effects of prestimulation on the electromyographic response associated with the acoustic startle reaction in rats. Physiol Behav 8 (1972) 535-537
2. Braff D., Stone C., Callaway E., Geyer M., Glick I., and Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15 (1978) 339-343
3. Geyer M.A., Swerdlow N.R., Mansbach R.S., and Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25 (1990) 485-498
4. Mackeprang T., Kristiansen K.T., and Glenthoj B.Y. Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenia patients. Biol Psychiatry 52 (2002) 863-873
5. Parwani A., Duncan E.J., Bartlett E., Madonick S.H., Efferen T.R., Rajan R., et al. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 47 (2000) 662-669
6. Schall U., Schon A., Zerbin D., Eggers C., and Oades R.D. Event-related potentials during an auditory discrimination with prepulse inhibition in patients with schizophrenia, obsessive-compulsive disorder and healthy subjects. Inter J Neurosci 84 (1996) 15-33
7. Swerdlow N.R., Paulsen J., Braff D.L., Geyer M.A., and Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 58 (1995) 192-200
8. Grillon C., Morgan C.A., Davis M., and Southwick S.M. Effects of experimental context and specific threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44 (1998) 1027-1036
9. Geyer M.A., McIlwain K.L., and Paylor R. Mouse genetic models for prepulse inhibition: an early review. Mol Psyciatry 7 (2002) 1039-1053
10. Hoffman H.S., and Wible B.L. Role of weak signals in the acoustic startle. J Acoustic Soc Am 47 (1970) 489-497
11. Hoffman H.S., and Searle J.L. Acoustic and temporal factors in the evocation of startle. J Acoustic Soc Am 43 (1968) 269-282
12. Ison J.R., McAdam D.W., and Hammond G.R. Latency and amplitude changes in the acoustic startle reflex of the rat produced by variation in auditory prestimulation. Physiol Behav 10 (1973) 1035-1039
13. Swerdlow N.R., Shoemaker J.M., Auerbach P.P., Pitcher L., Goins J., and Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology 174 (2004) 452-462
14. Swerdlow N.R., Talledo J., Sutherland A.N., Nagy D., and Shoemaker J.M. Antipsychotic effects on prepulse inhibition in normal and "low gating" humans and rats. Neuropsychopharmacology 31 (2006) 2001-2021
15. Graham F.K. The more or less startling effects of weak prestimulation. Psychophysiology 12 (1975) 238-248
16. Hazlett E.A., Romero M.J., Haznedar M.M., New A.S., Goldstein K.E., Newmark R.E., et al. Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophrenia Res 93 (2007) 288-295
17. Ludewig K., Geyer M.A., and Vollenweider F.X. Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry 54 (2003) 121-128
18. Cadenhead K.S., Swerdlow N.R., Shafer K.M., Diaz M., and Braff D.L. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorders deficits. Am J Psychiatry 10 (2000) 1660-1668
19. Hong L.E., Summerfelt A., Wonodi I., Adami H., Buchanan R.W., and Thaker G.K. Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval. Am J Psychiatry 164 (2007) 61-65
20. Kumari V., Soni W., Mathew V.M., and Sharma T. Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry 57 (2000) 609-614
21. Aasen I., Kolli L., and Kumari V. Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological treatment studies. J Psychopharmacol 19 (2005) 39-45
22. Reijmers L.G., and Peeters B.W. Acoustic prepulses can facilitate the startle reflex in rats: discrepancy between rat and human data. Brain Res Bull 35 (1994) 337-338
23. Bale T.L., and Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Ann Rev Pharmacol Toxicol 44 (2004) 525-557
24. Berridge C.W., and Dunn A.J. CRF and restraint stress decrease exploratory behavior in hypophysectomized rats. Pharmacol Biochem Behav 34 (1989) 517-519
25. Swanson L.W., Sawchenko P.E., Rivier J., and Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36 (1983) 165-186
26. Bakshi V.P., and Geyer M.A. Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by dizocilpine administration in rats. Neuroscience 92 (1999) 113-121
27. 1 receptor mRNA expression. J Neurosci 15 (1995) 6340-6350
28. De Souza E.B. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution. J Neurosci 7 (1987) 88-100
29. Radulovic J., Sydow S., and Spiess J. Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J Neurosci Res 54 (1998) 507-521
30. Swerdlow N.R., Braff D.L., Taaid N., and Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51 (1994) 139-154
31. Conti L.H. Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats. Eur J Pharmacol 507 (2005) 125-134
32. Conti L.H., Berridge C.W., and Tayler J.E. Both corticotropin-releasing factor and apomorphine reduce prepulse inhibition following repeated central infusion of corticotropin-releasing factor. Pharm Biochem Beh 85 (2006) 261-272
33. Conti L.H., Murry J.D., Ruiz M.A., and Printz M.P. Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology 161 (2002) 296-303
34. 2 exert both additive and opposing influences on startle defensive behavior. J Neurosci 24 (2004) 6545-6552
35. Vinkers C.H., Risbrough V.B., Geyer M.A., Caldwell S., Low M.J., and Hauger R.L. Role of dopamine D1 and D2 receptors in CRF-induced disruption of prepulse inhibition. Pharmacol Biochem Behav 86 (2007) 550-558
36. Dirks A., Groenink L., Schipholt M.I., van der Gugten J., Hijzen T.H., Geyer M.A., et al. Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biol Psychiatry 51 (2002) 583-590
37. Dirks A., Groenink L., Westphal K.G., Olivier J.D., Verdouw P.M., van der Gugten J., et al. Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs. Neuropsychopharmacology 28 (2003) 1790-1798
38. Groenink L., Dirks A., Verdouw P.M., de Graaff M., Peeters B.W., Millan M.J., et al. CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF. Biol Psychiatry 63 (2008) 360-368
39. Banki C.M., Bissette G., Arato M., O'Connor L., and Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 144 (1987) 873-877
40. Bremner J.D., Licinio J., Darnell A., Krystal J.H., Owens M.J., Southwick S.M., et al. Elevated CRF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 154 (1997) 624-629
41. Chappell P., Leckman J., Goodman W., Bissette G., Pauls D., Anderson G., et al. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Biol Psychiatry 39 (1996) 776-783
42. Forman S.D., Bissette G., Yao J., Nemeroff C.B., and van Kammen D.P. Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia. Schizophrenia Res 12 (1994) 43-51
43. Sautter F.J., Bissette G., Wiley J., Manquno-Mire G., Schoenbachler B., Meyers L., et al. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD and healthy control subjects. Biol Psychiatry 54 (2003) 1382-1388
44. Ludewig S., and Ludewig K. No prepulse inhibition deficits in patients with unipolar depression. Depress Anxiety 17 (2003) 224-225
45. Perry W., Minassian A., and Feifel D. Prepulse inhibition in patients with non-psychotic major depressive disorder. J Affect Disord 81 (2004) 179-184
46. Nemeroff C.B. Psychopharmacology of affective disorders in the 21st century. Biol Psychiatry 44 (1998) 517-525
47. Herringa R.J., Roseboom P.H., and Kalin N.H. Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenia subjects. Neuropsychopharmacology 31 (2006) 1822-1831
48. Faraday M.M., O'Donoghue V.A., and Grunberg N.E. Effects of nicotine and stress on startle amplitude and sensory gating depend on rats strain and sex. Pharmacol Biochem Behav 62 (1999) 273-284
49. Hall F.S., Huang S., and Fong G. Effects of isolation-rearing on acoustic startle and pre-pulse inhibition in Wistar and fawn hooded rats. Ann N Y Acad Sci 821 (1997) 542-544
50. Varty G.B., and Geyer M.A. Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and FisherF344 rats. Behav Neurosci 112 (1998) 1450-1457
51. Palmer A.A., Dulawa S.C., Mottiwala A.A., Conti L.H., Geyer M.A., and Printz M.P. Prepulse inhibition startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci 114 (2000) 374-388
52. Palmer A.A., Breen L.L., Flodman P., Conti L.H., Spence M.A., and Printz M.P. Identification of quantitative trait loci for prepulse inhibition. Psychopharmacology 165 (2003) 270-279
53. Swerdlow N.R., Breier M., Mora A.B., Ko D., and Shoemaker J.M. A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating. Pharmacol Biochem Behav 88 (2008) 280-290
54. Swerdlow N.R., Shoemaker J.M., Pitcher L., Platten A., Kuczenski R., Eleey C.C., et al. Genetic differences in startle gating-disruptive effects of apomorphine: Evidence for central mediation. Behav Neurosci 116 (2002) 682-690
55. 2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats. Psychopharmacology 151 (2000) 38-48
56. Sutherland J.E., Page M.E., and Conti L.H. The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats. Pharmacol Biochem Behav 89 (2008) 324-337
57. Mansbach R.S., and Geyer M.A. Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine. Psychopharmacology 105 (1991) 162-168
58. Swerdlow N.R., Platten A., Shoemaker J., Pitcher L., and Auerbach P. Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology 158 (2001) 230-240
59. Plappert C.F., Pilz P.K.D., and Schnitzler H.U. Factors governing prepulse inhibition and prepulse facilitation of the acoustic startle response in mice. Behav Brain Res 152 (2004) 403-412
60. Varty G.B., Walters N., Cohen-Williams M., and Carey G.J. Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. Eur J Pharmacol 424 (2001) 27-36
61. Meloni E.G., Gerety L.P., Knoll A.T., Cohen B.M., and Carlezon W.A. Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J Neurosci 26 (2006) 3855-3863
62. Anokhin A.P., Heath A.C., Myers E., Ralano A., and Wood S. Genetic influences on prepulse inhibition of the startle reflex in humans. Neurosci Lett 353 (2003) 45-48
63. Greenwood T.A., Braff D.L., Light G.A., Cadenhead K.S., Calkins M.E., Dobie D.J., et al. Initial heritability analyses of endophenotypic measure for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 64 (2007) 1242-1250
64. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156 (2001) 117-154
65. Ellenbroek B.A., Geyer M.A., and Cools A.R. The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J Neurosci 15 (1995) 7604-7611